Logo image of ICL

ICL GROUP LTD (ICL) Stock Fundamental Analysis

NYSE:ICL - New York Stock Exchange, Inc. - IL0002810146 - Common Stock - Currency: USD

6.36  -0.01 (-0.16%)

After market: 6.36 0 (0%)

Fundamental Rating

5

Taking everything into account, ICL scores 5 out of 10 in our fundamental rating. ICL was compared to 85 industry peers in the Chemicals industry. ICL scores excellent on profitability, but there are some minor concerns on its financial health. ICL has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ICL had positive earnings in the past year.
In the past year ICL had a positive cash flow from operations.
In the past 5 years ICL has always been profitable.
Each year in the past 5 years ICL had a positive operating cash flow.
ICL Yearly Net Income VS EBIT VS OCF VS FCFICL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.60%, ICL is in the better half of the industry, outperforming 68.24% of the companies in the same industry.
The Return On Equity of ICL (7.11%) is better than 62.35% of its industry peers.
With a decent Return On Invested Capital value of 6.18%, ICL is doing good in the industry, outperforming 63.53% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ICL is significantly above the industry average of 7.05%.
The 3 year average ROIC (13.92%) for ICL is well above the current ROIC(6.18%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.6%
ROE 7.11%
ROIC 6.18%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.92%
ROIC(5y)10.85%
ICL Yearly ROA, ROE, ROICICL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

ICL has a better Profit Margin (5.95%) than 75.29% of its industry peers.
In the last couple of years the Profit Margin of ICL has declined.
ICL has a better Operating Margin (11.33%) than 65.88% of its industry peers.
In the last couple of years the Operating Margin of ICL has declined.
Looking at the Gross Margin, with a value of 32.98%, ICL is in the better half of the industry, outperforming 65.88% of the companies in the same industry.
ICL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.33%
PM (TTM) 5.95%
GM 32.98%
OM growth 3Y-13.08%
OM growth 5Y-4.23%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
ICL Yearly Profit, Operating, Gross MarginsICL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ICL is creating some value.
Compared to 1 year ago, ICL has about the same amount of shares outstanding.
Compared to 5 years ago, ICL has more shares outstanding
The debt/assets ratio for ICL has been reduced compared to a year ago.
ICL Yearly Shares OutstandingICL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ICL Yearly Total Debt VS Total AssetsICL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

The Debt to FCF ratio of ICL is 3.04, which is a good value as it means it would take ICL, 3.04 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 3.04, ICL belongs to the best of the industry, outperforming 87.06% of the companies in the same industry.
A Debt/Equity ratio of 0.33 indicates that ICL is not too dependend on debt financing.
ICL has a Debt to Equity ratio of 0.33. This is in the better half of the industry: ICL outperforms 70.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 3.04
Altman-Z N/A
ROIC/WACC0.8
WACC7.75%
ICL Yearly LT Debt VS Equity VS FCFICL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

ICL has a Current Ratio of 1.54. This is a normal value and indicates that ICL is financially healthy and should not expect problems in meeting its short term obligations.
ICL has a Current ratio of 1.54. This is in the lower half of the industry: ICL underperforms 61.18% of its industry peers.
A Quick Ratio of 0.84 indicates that ICL may have some problems paying its short term obligations.
ICL has a worse Quick ratio (0.84) than 68.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.84
ICL Yearly Current Assets VS Current LiabilitesICL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

ICL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.33%.
Looking at the last year, ICL shows a decrease in Revenue. The Revenue has decreased by -8.59% in the last year.
ICL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.35% yearly.
EPS 1Y (TTM)-33.33%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-20%
Revenue 1Y (TTM)-8.59%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%-5.27%

3.2 Future

ICL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.38% yearly.
ICL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.96% yearly.
EPS Next Y15.35%
EPS Next 2Y15.01%
EPS Next 3Y10.38%
EPS Next 5YN/A
Revenue Next Year3.86%
Revenue Next 2Y3.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICL Yearly Revenue VS EstimatesICL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B 10B
ICL Yearly EPS VS EstimatesICL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.74, the valuation of ICL can be described as correct.
The rest of the industry has a similar Price/Earnings ratio as ICL.
When comparing the Price/Earnings ratio of ICL to the average of the S&P500 Index (27.63), we can say ICL is valued slightly cheaper.
A Price/Forward Earnings ratio of 14.51 indicates a correct valuation of ICL.
ICL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.85. ICL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.74
Fwd PE 14.51
ICL Price Earnings VS Forward Price EarningsICL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICL indicates a somewhat cheap valuation: ICL is cheaper than 62.35% of the companies listed in the same industry.
78.82% of the companies in the same industry are more expensive than ICL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.87
EV/EBITDA 7.26
ICL Per share dataICL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

ICL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ICL may justify a higher PE ratio.
PEG (NY)1.09
PEG (5Y)N/A
EPS Next 2Y15.01%
EPS Next 3Y10.38%

3

5. Dividend

5.1 Amount

ICL has a Yearly Dividend Yield of 2.94%.
ICL's Dividend Yield is a higher than the industry average which is at 3.98.
ICL's Dividend Yield is comparable with the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 2.94%

5.2 History

The dividend of ICL decreases each year by -1.81%.
ICL has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-1.81%
Div Incr Years0
Div Non Decr Years0
ICL Yearly Dividends per shareICL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

ICL pays out 61.67% of its income as dividend. This is not a sustainable payout ratio.
DP61.67%
EPS Next 2Y15.01%
EPS Next 3Y10.38%
ICL Yearly Income VS Free CF VS DividendICL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B
ICL Dividend Payout.ICL Dividend Payout, showing the Payout Ratio.ICL Dividend Payout.PayoutRetained Earnings

ICL GROUP LTD

NYSE:ICL (4/21/2025, 7:16:04 PM)

After market: 6.36 0 (0%)

6.36

-0.01 (-0.16%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners23.59%
Inst Owner Change-0.47%
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap8.21B
Analysts46.67
Price Target0.05 (-99.21%)
Short Float %0.42%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield 2.94%
Yearly Dividend0.19
Dividend Growth(5Y)-1.81%
DP61.67%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-12 2025-03-12 (0.1469338)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.04%
Min EPS beat(2)0.9%
Max EPS beat(2)25.18%
EPS beat(4)4
Avg EPS beat(4)11.74%
Min EPS beat(4)0.9%
Max EPS beat(4)25.18%
EPS beat(8)6
Avg EPS beat(8)11.15%
EPS beat(12)9
Avg EPS beat(12)20.36%
EPS beat(16)13
Avg EPS beat(16)23.32%
Revenue beat(2)0
Avg Revenue beat(2)-2.77%
Min Revenue beat(2)-4.13%
Max Revenue beat(2)-1.41%
Revenue beat(4)0
Avg Revenue beat(4)-3.07%
Min Revenue beat(4)-5.35%
Max Revenue beat(4)-1.41%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.07%
PT rev (3m)-3.74%
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)-9.17%
EPS NY rev (1m)3.03%
EPS NY rev (3m)6.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 16.74
Fwd PE 14.51
P/S 1.2
P/FCF 10.87
P/OCF 5.59
P/B 1.43
P/tB 1.69
EV/EBITDA 7.26
EPS(TTM)0.38
EY5.97%
EPS(NY)0.44
Fwd EY6.89%
FCF(TTM)0.59
FCFY9.2%
OCF(TTM)1.14
OCFY17.89%
SpS5.3
BVpS4.44
TBVpS3.76
PEG (NY)1.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.6%
ROE 7.11%
ROCE 8.62%
ROIC 6.18%
ROICexc 6.5%
ROICexgc 7.24%
OM 11.33%
PM (TTM) 5.95%
GM 32.98%
FCFM 11.04%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.92%
ROIC(5y)10.85%
ROICexc(3y)14.73%
ROICexc(5y)11.49%
ROICexgc(3y)16.32%
ROICexgc(5y)12.74%
ROCE(3y)19.95%
ROCE(5y)15.58%
ROICexcg growth 3Y-14.77%
ROICexcg growth 5Y-1.16%
ROICexc growth 3Y-14.65%
ROICexc growth 5Y-1.5%
OM growth 3Y-13.08%
OM growth 5Y-4.23%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 3.04
Debt/EBITDA 1.39
Cap/Depr 119.63%
Cap/Sales 10.42%
Interest Coverage 6.35
Cash Conversion 107.08%
Profit Quality 185.5%
Current Ratio 1.54
Quick Ratio 0.84
Altman-Z N/A
F-Score4
WACC7.75%
ROIC/WACC0.8
Cap/Depr(3y)138.38%
Cap/Depr(5y)133.57%
Cap/Sales(3y)9.41%
Cap/Sales(5y)9.89%
Profit Quality(3y)123.56%
Profit Quality(5y)409.37%
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%-20%
EPS Next Y15.35%
EPS Next 2Y15.01%
EPS Next 3Y10.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.59%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%-5.27%
Revenue Next Year3.86%
Revenue Next 2Y3.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.08%
EBIT growth 3Y-13.56%
EBIT growth 5Y0.9%
EBIT Next Year82.26%
EBIT Next 3Y21.85%
EBIT Next 5YN/A
FCF growth 1Y-7.36%
FCF growth 3Y18.48%
FCF growth 5Y12.66%
OCF growth 1Y-7.96%
OCF growth 3Y11.29%
OCF growth 5Y8.15%